EUVIMEDEUVIMED entdecken
Crossref

Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study

Abdullah Özkaya

Beyoglu Eye Journal · 2017

DOI: 10.14744/bej.2017.13007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Beyoglu Eye Journal, 2017. Verfasst von Abdullah Özkaya.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Özkaya, A. (2017). Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study. Beyoglu Eye Journal. https://doi.org/10.14744/bej.2017.13007

Vancouver

Özkaya A. Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study. Beyoglu Eye Journal. 2017. doi:10.14744/bej.2017.13007

BibTeX
@article{zkaya2017,
  author = {Özkaya, Abdullah},
  title = {Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study},
  journal = {Beyoglu Eye Journal},
  year = {2017},
  doi = {10.14744/bej.2017.13007}
}
Kostenlos starten →